Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer
- PMID: 10987269
Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer
Abstract
Hypoxia-inducible factor 1alpha (HIF-1alpha) is a transcriptional factor that regulates genes involved in response to hypoxia and promotes neoangiogenesis, which are considered essential for tumor growth and progression. Using immunohistochemistry, we investigated the influence of HIF-1alpha expression on prognosis in 91 patients with cervical cancer stage pT1b. In univariate and multivariate analysis, patients with strong expression of HIF-1alpha had a significantly shorter overall survival time (P = 0.0307, log-rank test) and disease-free survival time (P < 0.0001, log-rank test) compared with those with moderate to absent HIF-1alpha expression. HIF-1alpha expression is a strong independent prognostic marker in early stage cervical cancer.
Similar articles
-
Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy.Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):494-501. doi: 10.1016/s0360-3016(02)04579-0. Int J Radiat Oncol Biol Phys. 2003. PMID: 12738326
-
Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis.Cancer. 2001 Jul 1;92(1):165-71. doi: 10.1002/1097-0142(20010701)92:1<165::aid-cncr1305>3.0.co;2-f. Cancer. 2001. PMID: 11443623
-
Overexpression of hypoxia-inducible factor-1α is a predictor of poor prognosis in cervical cancer: a clinicopathologic study and a meta-analysis.Int J Gynecol Cancer. 2014 Jul;24(6):1054-64. doi: 10.1097/IGC.0000000000000162. Int J Gynecol Cancer. 2014. PMID: 24978711
-
How does hypoxia inducible factor-1α participate in enhancing the glycolysis activity in cervical cancer?Ann Diagn Pathol. 2013 Jun;17(3):305-11. doi: 10.1016/j.anndiagpath.2012.12.002. Epub 2013 Feb 1. Ann Diagn Pathol. 2013. PMID: 23375385 Review.
-
Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer.Thorax. 2009 Dec;64(12):1082-9. doi: 10.1136/thx.2009.115691. Epub 2009 Sep 23. Thorax. 2009. PMID: 19778933 Review.
Cited by
-
Neoadjuvant Chemotherapy With the Angiogenesis Inhibitor Bevacizumab for Locally Advanced Cervical Cancer.In Vivo. 2024 Nov-Dec;38(6):3068-3077. doi: 10.21873/invivo.13791. In Vivo. 2024. PMID: 39477433 Free PMC article.
-
HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma.Cell Death Discov. 2024 Jul 24;10(1):338. doi: 10.1038/s41420-024-02100-5. Cell Death Discov. 2024. PMID: 39048564 Free PMC article.
-
Insights into the oral microbiota in human systemic cancers.Front Microbiol. 2024 May 2;15:1369834. doi: 10.3389/fmicb.2024.1369834. eCollection 2024. Front Microbiol. 2024. PMID: 38756728 Free PMC article. Review.
-
The effect of curcumin on hypoxia in the tumour microenvironment as a regulatory factor in cancer.Arch Med Sci. 2023 Aug 14;19(6):1616-1629. doi: 10.5114/aoms/171122. eCollection 2023. Arch Med Sci. 2023. PMID: 38058727 Free PMC article.
-
NFR2/ABC transporter axis in drug resistance of breast cancer cells.Mol Biol Rep. 2023 Jun;50(6):5407-5414. doi: 10.1007/s11033-023-08384-7. Epub 2023 Apr 20. Mol Biol Rep. 2023. PMID: 37081307 Review.